Hai-Xin Yuan

Hai-Xin Yuan

Auto-generated profile, based on publicly available information

Hai-Xin Yuan

Basic Medicine Research and Innovation Center for Novel Target and Therapeutic Intervention (Ministry of Education), Department of Urology and Department of Cancer Center of the Second Affiliated Hospital, College of Pharmacy

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2020 in Liver International
Verified
Journal Article
Closed access
PDF file
XLXiaoya Li
Xiaoya Li
TWTian‐Xiang Wang
Tian‐Xiang Wang
XHXinmei Huang
Xinmei Huang
YLYue Li
Yue Li
TSTiange Sun
Tiange Sun
HYHai‐Xin Yuan
Hai‐Xin Yuan

16 January 2018 in Oncogene
Verified
Journal Article
Closed access
PDF file
MLMeng-Xi Liu
Meng-Xi Liu
LJLei Jin
Lei Jin
SSSi-Jia Sun
Si-Jia Sun
PLPeng Liu
Peng Liu
XFXu Feng
Xu Feng
YXYue Xiong
Yue Xiong

6 February 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
FLFu-Long Li
Fu-Long Li
JLJin-Ping Liu
Jin-Ping Liu
RBRuo-Xuan Bao
Ruo-Xuan Bao
GYGuoQuan Yan
GuoQuan Yan
XFXu Feng
Xu Feng
HYHai-Xin Yuan
Hai-Xin Yuan
Abstract: Enhanced glycolysis in cancer cells has been linked to cell protection from DNA damaging signals, although the mechanism is largely unknown. The 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3) catalyzes the generation of fructose-2,6-bisphosphate, a potent allosteric stimulator of glycolysis. Intriguingly, among the four members of PFKFB family, PFKFB3 is uniquely localized in the nucleus, although the reason remains unclear. Here we show that chemotherapeutic agent cisplatin promotes glycolysis, which is suppressed by PFKFB3 deletion. Mechanistically, cisplatin induces PFKFB3 acetylation at lysine 472 (K472), which impairs activity of the nuclear localization signal (NLS) and accumulates PFKFB3 in the cytoplasm. Cytoplasmic accumulation of PFKFB3 facilitates its phosphorylation by AMPK, leading to PFKFB3 activation and enhanced glycolysis. Inhibition of PFKFB3 sensitizes tumor to cisplatin treatment in a xenograft model. Our findings reveal a mechanism for cells to stimulate glycolysis to protect from DNA damage and potentially suggest a therapeutic strategy to sensitize tumor cells to genotoxic agents by targeting PFKFB3.

12 January 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
HYHuirong Yang
Huirong Yang
ZYZishuo Yu
Zishuo Yu
XCXizi Chen
Xizi Chen
JLJiabei Li
Jiabei Li
NLNingning Li
Ningning Li
YXYanhui Xu
Yanhui Xu
Tuberous sclerosis complex (TSC) integrates upstream stimuli and regulates cell growth by controlling the activity of mTORC1. TSC complex functions as a GTPase-activating protein (GAP) towards small GTPase Rheb and inhibits Rheb-mediated activation of mTORC1. Mutations in TSC genes cause tuberous sclerosis. In this study, the near-atomic resolution structure of human TSC complex reveals an arch-shaped architecture, with a 2:2:1 stoichiometry of TSC1, TSC2, and TBC1D7. This asymmetric complex consists of two interweaved TSC1 coiled-coil and one TBC1D7 that spans over the tail-to-tail TSC2 dimer. The two TSC2 GAP domains are symmetrically cradled within the core module formed by TSC2 dimerization domain and central coiled-coil of TSC1. Structural and biochemical analyses reveal TSC2 GAP-Rheb complimentary interactions and suggest a catalytic mechanism, by which an asparagine thumb (N1643) stabilizes γ-phosphate of GTP and accelerate GTP hydrolysis of Rheb. Our study reveals mechanisms of TSC complex assembly and GAP activity.

1 September 2016 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
XFXu Feng
Xu Feng
PLPeng Liu
Peng Liu
XZXin Zhou
Xin Zhou
MLMeng-Tian Li
Meng-Tian Li
FLFu-Long Li
Fu-Long Li
KGKun-Liang Guan
Kun-Liang Guan
The thromboxane A2 receptor (TP) has been implicated in restenosis after vascular injury, which induces vascular smooth muscle cell (VSMC) migration and proliferation. However, the mechanism for this process is largely unknown. In this study, we report that TP signaling induces VSMC migration and proliferation through activating YAP/TAZ, two major downstream effectors of the Hippo signaling pathway. The TP-specific agonists [1S-[1α,2α(Z),3β(1E,3S*),4 α]]-7-[3-[3-hydroxy-4-(4-iodophenoxy)-1-butenyl]-7-oxabicyclo[2.2.1]hept-2-yl]-5-heptenoic acid (I-BOP) and 9,11-dideoxy-9α,11α-methanoepoxy-prosta-5Z,13E-dien-1-oic acid (U-46619) induce YAP/TAZ activation in multiple cell lines, including VSMCs. YAP/TAZ activation induced by I-BOP is blocked by knockout of the receptor TP or knockdown of the downstream G proteins Gα12/13. Moreover, Rho inhibition or actin cytoskeleton disruption prevents I-BOP-induced YAP/TAZ activation. Importantly, TP activation promotes DNA synthesis and cell migration in VSMCs in a manner dependent on YAP/TAZ. Taken together, thromboxane A2 signaling activates YAP/TAZ to promote VSMC migration and proliferation, indicating YAP/TAZ as potential therapeutic targets for cardiovascular diseases.

7 October 2019 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
TWTian-Xiang Wang
Tian-Xiang Wang
JLJun-Yun Liang
Jun-Yun Liang
CZCheng Zhang
Cheng Zhang
YXYue Xiong
Yue Xiong
KGKun-Liang Guan
Kun-Liang Guan
HYHai-Xin Yuan
Hai-Xin Yuan
Ferroptosis is a non-apoptotic form of cell death characterized by the iron-dependent lipid peroxidation and is implicated in several human pathologies, such as tissue ischemia, neurodegeneration, and cancer. Ferroptosis appears to be high cell-context dependent and the regulation of ferroptosis by physiological or pathological conditions are unclear. Here, we report that tumor-derived IDH1 mutation sensitizes cells to ferroptosis. Deletion of the mutant IDH1 allele in IDH1 heterozygous tumor cells or pharmacological inhibition of mutant IDH1 to produce the oncometabolite D-2-hydroxyglutarate (D-2-HG) confers resistance to erastin-induced ferroptosis. Conversely, ectopic expression of mutant IDH1 or treatment of cells with cell-permeable D-2-HG promotes the accumulation of lipid reactive oxygen species (ROS) and subsequently ferroptosis. Mechanistically, mutant IDH1 reduces the protein level of the glutathione peroxidase 4 (GPX4), a key enzyme in removing lipid ROS and ferroptosis, and promotes depletion of glutathione. Our results uncover a new role of mutant IDH1 and 2-HG in ferroptosis.